Nephrology Clinical Trials Institute LLC is categorized under Nephrologists in Halethorpe, MD and active since 2009.
Nephrology Clinical Trials Institute LLC was established in 2009, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Nephrologists business, which does work in the B2C market, and is classified as a Nephrologists, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact at the company’s single location by writing to 1589 Sulphur Spring Road # 109, Halethorpe, Maryland MD 21227 or by phoning (443) 423-1164. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Nephrology Clinical Trials Institute LLC |
| Address: | 1589 Sulphur Spring Road # 109, Halethorpe, Maryland 21227 |
| Phone Number: | (443) 423-1164 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2009 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Nephrologists |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Nephrology Clinical Trials Institute LLC was started in 2009 to provide professional Nephrologists under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact for inquiries that concern Nephrology Clinical Trials Institute LLC by calling the company number (443) 423-1164, as your correspondence is most welcome. Additionally, the physical location of the single location of Nephrology Clinical Trials Institute LLC can be found at the coordinates 39.248981,-76.687199 as well as the street address 1589 Sulphur Spring Road # 109 in Halethorpe, Maryland 21227.
For its online presence, you may visit Nephrology Clinical Trials Institute LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.